ArticleOncoimmunology2022

Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer.

Junko Matsuzaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.